Clinical trial

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

NCT00843193

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention INTRAVENOUS GSK679586 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention INTRAVENOUS PLACEBO Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record FLUTICASONE PROPIONATE Normalized identity: fluticasone propionateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-09

PhasePHASE2

Conditions

Asthmaverified · MONDO: asthma

Interventions

INTRAVENOUS GSK679586DRUG

INTRAVENOUS PLACEBODRUG

FLUTICASONE PROPIONATEDRUG · verified · RxNorm: fluticasone propionate

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1 PittsburghPennsylvania, United States1 PortlandOregon, United States1 WarsawPoland1 MarseilleFrance1 MontpellierFrance1 MadisonWisconsin, United States1 StrasbourgFrance1 LilleFrance1 KrakowPoland1 LodzPoland1 NantesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00843193 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.